PE20030145A1 - AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS - Google Patents
AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREASInfo
- Publication number
- PE20030145A1 PE20030145A1 PE2002000439A PE2002000439A PE20030145A1 PE 20030145 A1 PE20030145 A1 PE 20030145A1 PE 2002000439 A PE2002000439 A PE 2002000439A PE 2002000439 A PE2002000439 A PE 2002000439A PE 20030145 A1 PE20030145 A1 PE 20030145A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- diphenylethyl
- purin
- methyl
- agonist
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMBINACION DE INHALACION DE UN AGONISTA SELECTIVO DEL RECEPTOR ADENOSINA A2a TAL COMO N-({9-[(2R,3R,4S,5R)-3,4-DIHIDROXI-5-(METOXIMETIL)TETRAHIDRO-2-FURANIL]-6-[(2,2-DIFENILETIL)AMINO]-9H-PURIN-2-IL}-METIL)-2-METIL-1-PROPANOSULFONAMIDA; CIS-(2R,3R,4S,5R)-2-(6-[(2,2-DIFENILETIL)AMINO]-2-{[(4-ISOPROPILCICLOHEXIL)AMINO]METIL}-9H-PURIN-9-IL)-5-(METOXIMETIL)TETRAHIDRO-3,4-FURANODIOL Y TRANS-(2R,3R,4S,5R)-2-(6-[(2,2-DIFENILETIL)AMINO]-2-{[(4-ISOPROPILCICLOHEXIL)AMINO]METIL}-9H-PURIN-9-IL)-5-(METOXIMETIL)TETRAHIDRO-3,4-FURANODIOL, 6-[(2,2-DIFENILETIL)AMINO]-9-{(2R,3R,4S,5S)-5-[(ETILAMINO)CARBONIL]-3,4-DIHIDROXITETRAHIDRO-2-FURANIL}-N-(2-[({[1-(2-PIRIDINIL)-4-PIPERIDINIL]AMINO}CARBONIL)AMINO]ETIL}-9H-PURIN-2-CARBOXAMIDA; ENTRE OTROS Y UN AGENTE ANTICOLINERGICO QUE NO ES UNA SAL DE TIOTROPIO Y PUEDE SER UNA SAL DE IPRATROPIO O UNA SAL DE OXITROPIO. LA COMBINACION SINERGICA DE UN ANTAGONISTA DEL RECEPTOR MUSCARINICO JUNTO CON UN AGONISTA A2A A TRAVES DE LA INHALACION NO PROVOCA EFECTOS PERIFERICOS NO DESEADOS Y PUEDE SER UTIL PARA EL TRATAMIENTO DE UNA ENFERMEDAD OBSTRUCTIVA DE LAS VIAS AEREAS, OTRA ENFERMEDAD INFLAMATORIAREFERS TO AN INHALATION COMBINATION OF A SELECTIVE AGONIST OF THE ADENOSINE A2a RECEPTOR SUCH AS N - ({9 - [(2R, 3R, 4S, 5R) -3,4-DIHYDROXY-5- (METOXIMETHYL) TETRAHYDRO-2-FURANIL ] -6 - [(2,2-DIPHENYLETHYL) AMINO] -9H-PURIN-2-IL} -MEthyl) -2-METHYL-1-PROPANOSULFONAMIDE; CIS- (2R, 3R, 4S, 5R) -2- (6 - [(2,2-DIPHENYLETHYL) AMINO] -2 - {[(4-ISOPROPYL CYCLOHEXYL) AMINO] METHYL} -9H-PURIN-9-IL) -5- (METOXIMETHYL) TETRAHYDRO-3,4-FURANODIOL AND TRANS- (2R, 3R, 4S, 5R) -2- (6 - [(2,2-DIPHENYLETHYL) AMINO] -2 - {[(4-ISOPROPYL CYCLOHEXIL ) AMINO] METHYL} -9H-PURIN-9-IL) -5- (METOXIMETHYL) TETRAHYDRO-3,4-FURANODIOL, 6 - [(2,2-DIPHENYLETHYL) AMINO] -9 - {(2R, 3R, 4S , 5S) -5 - [(ETHYLAMINE) CARBONYL] -3,4-DIHYDROXYTETHYDRO-2-FURANIL} -N- (2 - [({[1- (2-PYRIDINYL) -4-PIPERIDINYL] AMINO} CARBONYL) AMINO ] ETHYL} -9H-PURIN-2-CARBOXAMIDE; BETWEEN OTHERS AND AN ANTICHOLINERGIC AGENT WHICH IS NOT A THOOTROPE SALT AND MAY BE AN IPRATROPIUM SALT OR AN OXYTHROPIUM SALT. A2A AGONIST THROUGH INHALATION DOES NOT CAUSE UNWANTED PERIPHERAL EFFECTS AND MAY BE USEFUL FOR THE TREATMENT OF AN OBSTRUCTIVE AIRWAY DISEASE, OTHER INFLAMMATORY DISEASE
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29384201P | 2001-05-25 | 2001-05-25 | |
GB0129275A GB0129275D0 (en) | 2001-12-06 | 2001-12-06 | Pharmaceutical combination |
GB0210238A GB0210238D0 (en) | 2002-05-03 | 2002-05-03 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030145A1 true PE20030145A1 (en) | 2003-03-01 |
Family
ID=42632507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002000439A PE20030145A1 (en) | 2001-05-25 | 2002-05-24 | AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR036030A1 (en) |
EA (1) | EA200301153A1 (en) |
PE (1) | PE20030145A1 (en) |
TN (1) | TNSN03124A1 (en) |
-
2002
- 2002-05-24 EA EA200301153A patent/EA200301153A1/en unknown
- 2002-05-24 AR ARP020101928 patent/AR036030A1/en not_active Application Discontinuation
- 2002-05-24 TN TNPCT/EP2002/005725A patent/TNSN03124A1/en unknown
- 2002-05-24 PE PE2002000439A patent/PE20030145A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA200301153A1 (en) | 2004-04-29 |
AR036030A1 (en) | 2004-08-04 |
TNSN03124A1 (en) | 2005-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20011122A1 (en) | PURINE-2-ILCARBOXAMIDE DERIVATIVES AS SELECTIVE AGONISTS OF THE ADENOSINE A2a RECEPTOR | |
CO5601022A2 (en) | METHODS TO TREAT PATIENTS WHO ARE MOVING DISORDERS | |
AR068879A1 (en) | ORGANIC COMPOUNDS | |
JP2018522038A5 (en) | ||
CO5540324A2 (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES | |
JP2008517057A5 (en) | ||
RU2007137990A (en) | Adenosine Derivatives With A2A Receptor Activity | |
MEP35308A (en) | COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF | |
JP2007536277A5 (en) | ||
JP2007523178A5 (en) | ||
JP2009500443A5 (en) | ||
MA29799B1 (en) | ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS | |
AR041089A1 (en) | PROCEDURE AND PHARMACEUTICAL COMPOSITIONS TO TREAT ATEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED AFFECTIONS | |
JP2009501746A5 (en) | ||
WO2022251663A2 (en) | Novel universal anti-rna virus agents | |
NO20066012L (en) | Purine derivatives such as adenosine A1 receptor agonists and methods for their use | |
PE20071230A1 (en) | COMBINATIONS AND METHODS OF HCV INHIBITORS | |
RU2018106886A (en) | COMBINED THERAPIES FOR TREATMENT OF CANCER | |
JP2002539224A5 (en) | ||
Peart et al. | Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine | |
Cargnoni et al. | Role of A2A receptor in the modulation of myocardial reperfusion damage | |
PE20030145A1 (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE VIAS AREAS | |
PE20070622A1 (en) | ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS | |
Haywood et al. | Role of the purinergic signaling network in lung ischemia-reperfusion injury | |
AR039977A1 (en) | DICLOFENAC BASED COMPOSITION FOR THE TOPICAL TREATMENT OF OROPHARINGEA CAVITY AFFECTIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |